An official of Tobinco receiving the award
Excitement engulfed the Banquet Hall of the State House when popular anti- malaria drug ‘Lonart’, produced by Tobinco Pharmaceuticals, one of the leading pharmaceutical companies in Ghana, was adjudged the Chartered Institute of Marketing Ghana (CIMG) Product of the Year, 2014.
This was at the 26th Awards National Marketing Performance Awards organised by the institute last Saturday.
CIMG Awards is one of the most popular and celebrated awards in the country aimed at promoting high professional standards and to encourage excellence among marketing practitioners and to equally ensure an improved quality of products and services being offered by businesses.
With a vision of providing quality and affordable essential medicines, Samuel Amo Tobbin, the CEO of Tobinco Pharmaceuticals Limited, was awarded CIMG Marketing Man of The Year 2010 and in pursuit of this vision, the Tobinco Pharmaceuticals Limited was awarded CIMG Marketing Oriented organisation of The Year 2011 for consistency in meeting the nation’s health needs.
Lonart is undoubtedly the most widely patronised anti-malaria drug in the country.
The event, held annually in Accra, was on the theme: ‘The Future of Marketing: Evolve or Die’.
Marketing and Business Communications Manager, Ben Kpabi Tetteh commended the management and staff of the company, especially Mr Amo Tobbin for his dynamic leadership style.
He also expressed the company’s unflinching commitment to helping achieve the objectives of the Ghana Health Service (GHS), especially the eradication of malaria by the end of 2015.